Advertisement ChromaDex, Bruker enter into co-development pact for dietary supplement testing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ChromaDex, Bruker enter into co-development pact for dietary supplement testing

ChromaDex and a subsidiary of Bruker Corporation, Bruker Optics have entered into a co-development and co-marketing agreement for the promotion of new approach to dietary supplement testing.

The tie up is expected to capitalize on the extensive phytochemical and botanical reference standard capabilities of ChromaDex and will initially focus on the near infrared spectrometer (NIR) technology created by Bruker Optics.

ChromaDex and Bruker Optics said that with this collaboration, the producer of dietary supplement will be able to get the in-house capabilities of a contract laboratory without the associated start-up costs.

The new system will offer the dietary supplement producer to determine adulteration and will also help the manufacturer to quickly and accurately perform raw material identity testing.

ChromaDex co-founder and CEO Frank Jaksch said this novel approach to quality control testing will enable manufacturers to save time and money, while at the same time providing a robust solution to quality needs that will greatly benefit the industry.

"We have chosen to collaborate with Bruker on this because we believe the testing platform they have developed, when coupled with our products and knowledge, will prove to be the solution the market has long been seeking," Jaksch said.